FDA Wants To Hear Your Thoughts About CBD

FDA Seeking Public Comments With Regard To Cannabidiol

DISTRICT OF COLUMBIA: The US Food and Drug Administration is soliciting public comments with regard to the therapeutic utility and abuse liability of various substances, including cannabidiol (CBD). The agency will consider these comments prior to preparing a formal response to the World Health Organization, which is considering placing the substances within their international drug scheduling code. Cannabidiol is defined by the Read the full article…

DEA To Classify Liquid, Synthetic THC As A Schedule II Controlled Substance

DEA to classify liquid THC

DISTRICT OF COLUMBIA: Officials from the US Drug Enforcement Administration (DEA) have recommended that Syndros, a liquid form of synthetic THC, be classified as a Schedule II controlled substance under federal law. Food and Drug Administration (FDA) officials determined last year that the drug formulation is safe and effective for use by patients with cancer and AIDS. Two other synthetic Read the full article…

Federal Reclassification Of Marijuana Could Have Major Impact On Medical Uses

The DEA along with the U.S. Department of Health and Human Services and Office of National Drug Control Policy announced they would review marijuana's classification after multiple letters from senators last year, including Sen. Elizabeth Warren, D-Massachusetts, and Sen. Kirsten Gillibrand, D-New York.l

DISTRICT OF COLUMBIA: Federal authorities have announced that they are reviewing the possibility of loosening the classification of marijuana, and if this happens, it could have a far-reaching impact on how the substance is used in medical settings, experts said. Marijuana is currently classified as a Schedule I drug, meaning it is listed alongside heroin Read the full article…

DEA Eases Requirements For FDA-Approved Clinical Trials On Cannabidiol

These modifications will streamline the research process regarding CBD’s possible medicinal value and help foster ongoing scientific studies.

WASHINGTON: The United States Drug Enforcement Administration (DEA) recently eased some of the regulatory requirements imposed by the Controlled Substances Act (CSA) for those who are conducting FDA-approved clinical trials on cannabidiol (CBD), an extract of the marijuana plant.  These modifications will streamline the research process regarding CBD’s possible medicinal value and help foster ongoing scientific studies. Read the full article…

Did GW Pharmaceuticals (GWPH) Just Destroy The CBD-Product Industry?

The Food and Drug Administration (FDA) announced that products which contain cannabidiol (CBD) cannot be sold as dietary supplements.

DISTRICT OF COLUMBIA:  The Food and Drug Administration (FDA) announced that products which contain cannabidiol (CBD) cannot be sold as dietary supplements. The agency, however, left open the possibility that would it consider contrary evidence. The FDA’s website provides questions and answers pertaining its policies on marijuana. The way the questions were written provides avenues Read the full article…

Medical Marijuana Just Scored A Huge Victory At A San Francisco Hospital

San Francisco General Hospital is making strides in developing a marijuana-derived treatment for sickle-cell anemia.

CALIFORNIA:  San Francisco General Hospital is making strides in developing a marijuana-derived treatmentfor sickle-cell anemia, a blood disorder that affects over millions worldwide, including 10% of African Americans in the U.S. It causes severe pain throughout the body. The condition is currently treated using opiate painkillers, but researchers believe that CBD, one of the compounds in marijuana, could Read the full article…

Federal Restrictions On Pot Are Under Review

The first potential actualization on the federal rescheduling of marijuana is finally happening.

DISTRICT OF COLUMBIA: The federal government is reviewing its heavy-handed restrictions on marijuana, Food and Drug Administration officials confirmed Monday. This is potentially huge news for marijuana legalization and medical marijuana advocates. If the review finds any medical value in marijuana, it could mark the beginning of the most significant shift in American drug policy since the war on drugs Read the full article…

GW Pharmaceuticals Closes U.S. Public Offering; Cannabis-Based Medicines Progress

Cannabis-based medicines progress.

NORTH CAROLINA:  Yesterday, Salisbury, UK-based GW Pharmaceuticals plc announced the closing of its public offering of 1.7 million American Depositary Shares on the NASDAQ Global Market. When taken together with the full exercise of options for another 255,000 ADSs by the underwriters at $86.83/ADS, the offering totaled $169.8 million. Although some of the ADRs were sold by Read the full article…

Marijuana Considered for Looser Restrictions by U.S. FDA

Voters are relating to the message that legalization will end D.C.’s rampant discrimination when it comes marijuana enforcement

DISTRICT OF COLUMBIA:  U.S. regulators are studying whether restrictions on marijuana should be eased, a step toward decriminalizing the drug at the federal level. The Food and Drug Administration is conducting an analysis at the Drug Enforcement Administration’s request on whether the U.S. should downgrade the classification of marijuana as a Schedule 1 drug, said Read the full article…

Florida House, Gov. Scott Back Medical Marijuana Bill

“I’m a parent and a grandparent. I want to make sure my children, my grandchildren, have the access to the health care they want. So, I know the House has passed the bill. It’s going back to the Senate. If it passes, I’m going to sign it,” Scott told reporters this evening.

FLORIDA: Gov. Rick Scott said he will sign a medical marijuana bill poised to pass the Florida Senate, after the measure received overwhelming support today from the House as children whose lives hang in the balance looked on. “I’m a parent and a grandparent. I want to make sure my children, my grandchildren, have the Read the full article…